VERV logo

Verve Therapeutics (VERV) Net Income

Annual Net Income

-$200.07 M
-$42.68 M-27.12%

31 December 2023

VERV Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$50.13 M
-$328.00 K-0.66%

30 September 2024

VERV Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$197.03 M
-$4.38 M-2.27%

30 September 2024

VERV TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VERV Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.1%-9.6%-2.2%
3 y3 years-337.8%-120.4%-75.1%
5 y5 years---

VERV Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-337.8%at low-120.4%+7.1%-75.1%+1.5%
5 y5 years-936.8%at low-794.8%+7.1%-3416.4%+1.5%
alltimeall time-936.8%at low-794.8%+7.1%-3416.4%+1.5%

Verve Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$50.13 M(+0.7%)
-$197.03 M(+2.3%)
June 2024
-
-$49.80 M(+2.2%)
-$192.65 M(-2.1%)
Mar 2024
-
-$48.74 M(+0.8%)
-$196.83 M(-1.6%)
Dec 2023
-$200.07 M(+27.1%)
-$48.35 M(+5.7%)
-$200.07 M(+3.8%)
Sept 2023
-
-$45.76 M(-15.2%)
-$192.80 M(+0.3%)
June 2023
-
-$53.98 M(+3.9%)
-$192.23 M(+7.3%)
Mar 2023
-
-$51.98 M(+26.5%)
-$179.20 M(+13.9%)
Dec 2022
-$157.39 M
-$41.09 M(-9.1%)
-$157.39 M(+6.6%)
Sept 2022
-
-$45.19 M(+10.4%)
-$147.64 M(+17.9%)
June 2022
-
-$40.95 M(+35.7%)
-$125.20 M(-8.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$30.17 M(-3.7%)
-$137.22 M(+14.0%)
Dec 2021
-$120.31 M(+163.2%)
-$31.34 M(+37.8%)
-$120.31 M(+6.9%)
Sept 2021
-
-$22.75 M(-57.0%)
-$112.51 M(+13.9%)
June 2021
-
-$52.97 M(+299.3%)
-$98.75 M(+85.0%)
Mar 2021
-
-$13.26 M(-43.6%)
-$53.36 M(+16.8%)
Dec 2020
-$45.70 M(+136.8%)
-
-
Dec 2020
-
-$23.53 M(+161.7%)
-$45.70 M(+106.1%)
Sept 2020
-
-$8.99 M(+18.6%)
-$22.17 M(+68.2%)
June 2020
-
-$7.58 M(+35.3%)
-$13.18 M(+135.3%)
Mar 2020
-
-$5.60 M
-$5.60 M
Dec 2019
-$19.30 M
-
-

FAQ

  • What is Verve Therapeutics annual net profit?
  • What is the all time high annual net income for Verve Therapeutics?
  • What is Verve Therapeutics annual net income year-on-year change?
  • What is Verve Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Verve Therapeutics?
  • What is Verve Therapeutics quarterly net income year-on-year change?
  • What is Verve Therapeutics TTM net profit?
  • What is the all time high TTM net income for Verve Therapeutics?
  • What is Verve Therapeutics TTM net income year-on-year change?

What is Verve Therapeutics annual net profit?

The current annual net income of VERV is -$200.07 M

What is the all time high annual net income for Verve Therapeutics?

Verve Therapeutics all-time high annual net profit is -$19.30 M

What is Verve Therapeutics annual net income year-on-year change?

Over the past year, VERV annual net profit has changed by -$42.68 M (-27.12%)

What is Verve Therapeutics quarterly net profit?

The current quarterly net income of VERV is -$50.13 M

What is the all time high quarterly net income for Verve Therapeutics?

Verve Therapeutics all-time high quarterly net profit is -$5.60 M

What is Verve Therapeutics quarterly net income year-on-year change?

Over the past year, VERV quarterly net profit has changed by -$4.38 M (-9.56%)

What is Verve Therapeutics TTM net profit?

The current TTM net income of VERV is -$197.03 M

What is the all time high TTM net income for Verve Therapeutics?

Verve Therapeutics all-time high TTM net profit is -$5.60 M

What is Verve Therapeutics TTM net income year-on-year change?

Over the past year, VERV TTM net profit has changed by -$4.22 M (-2.19%)